DR. JOHN F DIPERSIO MD NPI 1730106295

NPI Information

  • NPI: 1730106295
  • Provider Name: DR. JOHN F DIPERSIO, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4921 PARKVIEW PL
    DIV IM BONE MARROW TRANSPLANT, 7TH FL
    SAINT LOUIS, MO
    ZIP 63110
  • Phone: (314) 454-8304

Map and Directions

Get Directions

NPI Details

DR. John F Dipersio, MD is a medical oncology internal medicine in Saint Louis, MO with 45 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. John F Dipersio, MD NPI is 1730106295. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Graduation Year:1980

The provider's business location address is:

4921 PARKVIEW PL
DIV IM BONE MARROW TRANSPLANT, 7TH FL
SAINT LOUIS, MO
ZIP 63110-032
Phone: (314) 454-8304
Fax: (314) 454-5902

The NPI 1730106295 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 7/17/2006 and was last updated on 4/25/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology105204MISSOURIYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1207688409MEDICAIDMISSOURI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.